10:35 AM EDT, 06/23/2025 (MT Newswires) -- IGC Pharma ( IGC ) said Monday it has collaborated with Tekton Research to add a new clinical trial site in Yukon, Oklahoma, for its phase 2 study assessing IGC-AD1 for agitation in Alzheimer's dementia.
The move diversifies the study's trial population and addresses regional healthcare disparities, IGC Pharma ( IGC ) said.